Comparison the efficacy of Heparin 10000 and 5000

5000 U/ml versus 10000 U/ml heparin lock anti-thrombosis effect on ventral venous catheter in hemodialysis patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211003052657N1

Enrollment

140

Registered

2021-11-25

Start date

2021-10-12

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Dependence on renal dialysis

Interventions

Intervention 1: In patients undergoing dialysis with permeate, to prevent thrombosis and maintain proper catheter function, it is necessary to thoroughly flush the catheter after each dialysis and hep

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patient Awareness Patient Satisfaction Consent of the treating physician that the vein is suitable for catheterization ( based on sonography result and suitable jugular without thrombosis and compressible) The first Right internal jugular vein catheterization No history of heparin allergy

Exclusion criteria

Exclusion criteria: Patient Dissatisfaction Physician Dissatisfaction Thrombosis or Vascular occlusion Bleeding Infection

Design outcomes

Primary

Measure	Time frame
Catheter thrombosis. Timepoint: Any time in 6 month. Method of measurement: Reduce the speed of the dialysis engine to more than 10% of the initial speed.	—

Secondary

Measure	Time frame
Bleeding. Timepoint: Any time. Method of measurement: Any abnormal bleeding.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Etebari

Tehran University of Medical Sciences

Etebari.mohsen@gmail.com+98 21 8822 1425

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026